Synopsis
Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 3-(2,2,2-trimethylhydrazine)propionate
2. 3-(2,2,2-trimethylhydrazinium)propionate
3. 3-tmhp
4. Met-88
5. Mildronat
6. Mildronate
7. Mindronate
8. N-trimethylhydrazine-3-propionate
9. Q-4224-ios
10. Quaterin
11. Trimethylhydraziniumpropionate
12. Vasonat
1. Mildronate
2. 76144-81-5
3. Quaterin
4. Kvaterin
5. Meldonium [inn]
6. 3-(2,2,2-trimethylhydrazine)propionate
7. Mildonate
8. Quaterine
9. 3-(2,2,2-trimethyldiazan-2-ium-1-yl)propanoate
10. 3-(2,2,2-trimethyldiazaniumyl)propanoate
11. Met88
12. Met-88
13. 3-[(trimethylazaniumyl)amino]propanoate
14. 73h7udn6ec
15. Meldonium (inn)
16. Unii-73h7udn6ec
17. 2-(2-carboxyethyl)-1,1,1-trimethylhydrazinium Hydroxide Inner Salt
18. Brn 3938272
19. Ccris 8536
20. Mildronate,meldonium
21. 3-[(trimethylammonio)amino]propanoate
22. 802032-35-5
23. Meldonium [mart.]
24. Meldonium [who-dd]
25. Amy530
26. Schembl1282002
27. Chembl2104708
28. Dtxsid10997497
29. Chebi:131843
30. Albb-024893
31. Bcp04503
32. Hy-b1836
33. Bdbm50007906
34. Stl282770
35. Akos002793781
36. Hydrazinium, 2-(2-carboxyethyl)-1,1,1-trimethyl-, Hydroxide, Inner Salt
37. Ac-2090
38. Ccg-358183
39. Db13723
40. Ncgc00164538-01
41. As-70972
42. Cs-0013905
43. Ft-0645227
44. Ft-0688222
45. 3-(2,2,2-trimethyldiazan-2-iumyl)propanoate
46. Meldonium Dihydrate, >=98% (hplc), Powder
47. D10504
48. 3-(1,1,1-trimethylhydrazinium-2-yl)propanoate
49. 9h-pyrido[2,3-b]indol-2-amine,n,9-dimethyl-
50. A838620
51. 3-(2,2,2-trimethylhydrazin-2-ium-1-yl)propanoate
52. Q-201406
53. Q4289752
54. F0001-1930
55. Meldonium Dihydrate, European Pharmacopoeia (ep) Reference Standard
| Molecular Weight | 146.19 g/mol |
|---|---|
| Molecular Formula | C6H14N2O2 |
| XLogP3 | -2.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 146.105527694 g/mol |
| Monoisotopic Mass | 146.105527694 g/mol |
| Topological Polar Surface Area | 52.2 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 112 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Adjuvants, Immunologic
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)
Cardiovascular Agents
Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)
C - Cardiovascular system
C01 - Cardiac therapy
C01E - Other cardiac preparations
C01EB - Other cardiac preparations
C01EB22 - Meldonium
Market Place
ANALYTICAL
ABOUT THIS PAGE
88
PharmaCompass offers a list of Meldonium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Meldonium manufacturer or Meldonium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Meldonium manufacturer or Meldonium supplier.
A D10504 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of D10504, including repackagers and relabelers. The FDA regulates D10504 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. D10504 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of D10504 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A D10504 supplier is an individual or a company that provides D10504 active pharmaceutical ingredient (API) or D10504 finished formulations upon request. The D10504 suppliers may include D10504 API manufacturers, exporters, distributors and traders.
click here to find a list of D10504 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A D10504 CEP of the European Pharmacopoeia monograph is often referred to as a D10504 Certificate of Suitability (COS). The purpose of a D10504 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of D10504 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of D10504 to their clients by showing that a D10504 CEP has been issued for it. The manufacturer submits a D10504 CEP (COS) as part of the market authorization procedure, and it takes on the role of a D10504 CEP holder for the record. Additionally, the data presented in the D10504 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the D10504 DMF.
A D10504 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. D10504 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of D10504 suppliers with CEP (COS) on PharmaCompass.
A D10504 written confirmation (D10504 WC) is an official document issued by a regulatory agency to a D10504 manufacturer, verifying that the manufacturing facility of a D10504 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting D10504 APIs or D10504 finished pharmaceutical products to another nation, regulatory agencies frequently require a D10504 WC (written confirmation) as part of the regulatory process.
click here to find a list of D10504 suppliers with Written Confirmation (WC) on PharmaCompass.
D10504 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of D10504 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right D10504 GMP manufacturer or D10504 GMP API supplier for your needs.
A D10504 CoA (Certificate of Analysis) is a formal document that attests to D10504's compliance with D10504 specifications and serves as a tool for batch-level quality control.
D10504 CoA mostly includes findings from lab analyses of a specific batch. For each D10504 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
D10504 may be tested according to a variety of international standards, such as European Pharmacopoeia (D10504 EP), D10504 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (D10504 USP).